comparemela.com

Latest Breaking News On - Orasis pharmaceuticals - Page 3 : comparemela.com

FDA to Review Novel Corrective Eye Drop Candidate for Presbyopia

The FDA has accepted for review the NDA for CSF-1 (pilocarpine hydrochloride 0.4%) for the treatment of presbyopia in adults.

FDA Accepts Orasis Pharmaceuticals' New Drug Application for CSF-1 for the Treatment of Presbyopia

Orasis Pharmaceuticals Submits New Drug Application for Investigational Novel Eye Drop Candidate, CSF-1, for the Treatment of Presbyopia

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.